Cite
HARVARD Citation
Daunt, A. et al. (2020). Validity of the UK early access to medicines scheme criteria for Remdesivir use in patients with COVID-19 disease. Journal of infection. 81 (4), pp. 647-679. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Daunt, A. et al. (2020). Validity of the UK early access to medicines scheme criteria for Remdesivir use in patients with COVID-19 disease. Journal of infection. 81 (4), pp. 647-679. [Online].